Acasti receives conditional acceptance for listing of course A shares on TSX-Venture Neptune Technology & Bioressources Inc. Acasti has received conditional approval from the Exchange for the report on its Class A talk about on the TSX-Venture . Acasti’s administration expects to waive all conditions with respect to the Listing prior to March 21, 2011. A complete news release will be issued by Acasti and Neptune at the time of the Listing, providing overview disclosure of the Listing and any related purchase.Studies have already been done on pets, which led the experts to conclude that there could be neurological, behavioral, developmental, hematological, and other changes due to contact with ultrasound waves. Theoretically, there are three factors that can pose the risk Intensity of ultrasound waves, duration of frequency and publicity of ultrasound sessions. Despite theoretical dangers, the technique can be nothing significantly less than a boon for the mother-to-be. There is no such advantage or any beneficial result of the technique in the correct growth and advancement of the fetus. It is not responsible to improve the outcome of pregnancy, but provides an possibility to the mom-to-end up being to visualize their child in womb and believe that unique bonding with her child who’s still to become born.